Eticlopride hydrochloride - CAS 97612-24-3
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C17H25ClN2O3.HCl
Molecular Weight:
377.31
COA:
Inquire
Targets:
Dopamine Receptor
Description:
Eticlopride hydrochloride is a selective dopamine D2/D3 receptor antagonist (Ki = 0.50 and 0.16 nM, respectively).
Brife Description:
dopamine D2/D3 receptor antagonist
Purity:
≥99% by HPLC
Related CAS:
84226-12-0 (free base)
Synonyms:
FLB 131; 3-Chloro-5-ethyl-N-[[(2S)-1-ethyl-2-pyrrolidinyl)methyl]-6-hydroxy-2-methoxy-benzamide hydrochloride
MSDS:
Inquire
Application:
Antipsychotic
InChIKey:
HFJFXXDHVWLIKX-YDALLXLXSA-N
InChI:
InChI=1S/C17H25ClN2O3.ClH/c1-4-11-9-13(18)16(23-3)14(15(11)21)17(22)19-10-12-7-6-8-20(12)5-2;/h9,12,21H,4-8,10H2,1-3H3,(H,19,22);1H/t12-;/m0./s1
Canonical SMILES:
CCC1=CC(=C(C(=C1O)C(=O)NCC2CCCN2CC)OC)Cl.Cl
1.Pharmacological analysis of the scratching produced by dopamine D2 agonists in squirrel monkeys.
Pellón R;Flores P;Alling K;Witkin JM;Katz JL J Pharmacol Exp Ther. 1995 Apr;273(1):138-45.
Several dopamine agonists, administered i.m., produced persistent, excessive and non-localized scratching in squirrel monkeys (Saimiri sciureus). Studies were conducted with a series of drugs to determine the pharmacological mechanisms responsible for this effect. All of the dopamine D2 agonists studied produced dose-related increases in scratching, whereas several dopamine D1 receptor agonists, indirect dopamine agonists and drugs acting on other receptors failed to produce dose-related increases in scratching. The scratching produced by D2 agonists was stereospecific; (-)-NPA produced scratching whereas its (+)-enantiomer was inactive up to doses 300-fold higher. Scratching induced by quinpirole was attenuated by both D2 and D1 antagonists, and this antagonism was stereospecific, with the D2 antagonist (-)-eticlopride, but not its enantiomer, active. Sensitivity developed to the effects of D2 agonists with the quinpirole dose-effect curve shifting to the left by a factor of approximately 64. Two partial D2 receptor agonists (SDZ 208-911 and SDZ 208-912) had limited efficacy in producing scratching, however, one partial D2 receptor agonist (terguride) was fully efficacious, suggesting that there are spare receptors for this effect.
2.Acute effects of sigma ligands on the electrophysiological activity of rat nigrostriatal and mesoaccumbal dopaminergic neurons.
Zhang J;Chiodo LA;Wettstein JG;Junien JL;Freeman AS Synapse. 1992 Aug;11(4):267-78.
The effects of acute i.v. administration of several sigma ligands on the single-unit activity of nigrostriatal and mesoaccumbal dopaminergic (DA) neurons were evaluated in chloral hydrate-anesthetized rats. DTG (1,3-di(o-tolyl)guanidine) did not alter DA neuronal activity at nontoxic doses and JO 1784 [(+)-N-cyclopropylmethyl-N-methyl-1,4-diphenyl-1-ethylbut-3-en-1-+ ++ylamine] was inactive. (+)-Pentazocine was more effective in increasing mesoaccumbal vs. nigrostriatal DA cell firing rates. BMY 14802(alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine-but anol) dose-dependently increased DA cell firing rate in both populations. The inhibition of nigrostriatal DA cell firing rate by (+)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine [(+)-3-PPP] was reversed by (-)-eticlopride and (+)-but not (-)-butaclamol, which supports previous evidence that (+)-3-PPP-induced inhibition is due to the DA agonist properties of the drug. From what is known of the pharmacological properties of these compounds, it is concluded that acute sigma receptor occupation does not markedly alter the firing rate of DA neurons. The dose-response curve for inhibition of nigrostriatal DA neuronal activity by the D2 DA agonist, quinpirole, was shifted to the right tenfold by BMY 14802 pretreatment (8 mg/kg, i.
3.Involvement of dopamine D2 receptors in the effect of cocaine on sexual behaviour and stretching-yawning of male rats.
Ferrari F;Giuliani D Neuropharmacology. 1997 Jun;36(6):769-77.
The effect of cocaine (7.5, 15 and 30 mg/kg) administered in acute or subchronic mode, on the mating behaviour of sexually active male rats varied in a dose- and mode-dependent manner. Regardless of mode of treatment, 30 mg/kg markedly impaired the rats copulatory ability and impairment continued for a week after suspension of subchronic treatment. An acute dose of 15 mg/kg reduced intromission frequency, while in subchronic mode it also reduced ejaculation latency. Mount frequency was increased by 7.5 and 15 mg/kg, but only on first injection. In the case of sexually-naive male rats, acute administration of cocaine (3-30 mg/kg) stimulated penile erections at 7.5 mg/kg and motor hyperactivity at all doses. (-) Eticlopride (0.025 and 0.05 mg/kg), a DA D2 antagonist, counteracted cocaine-induced motor hyperactivity but not penile erection, which it enhanced. (-) Eticlopride at the same doses also antagonized cocaine potentiation of lisuride (0.2 mg/kg)-induced behavioural effects. When male rats treated with subchronic cocaine (15 mg/kg) were injected with the DA D2 agonist SND 919 (0.1 mg/kg), they displayed a more marked stretching-yawning behaviour than control animals receiving SND 919 at the same dose.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Dopamine Receptor Products


Ordopidine
(CAS: 871351-60-9)

Ordopidine is a dopaminergic stabilizer. It can inhibit psychostimulant-induced hyperactivity and stimulate behaviour in states of hypoactivity. In May 2016, Ph...

CAS 125941-87-9 SCH 23390 hydrochloride

SCH 23390 hydrochloride
(CAS: 125941-87-9)

SCH 23390 hydrochloride is the hydrochloride salt of SCH 23390 which is a dopamine receptor antagonist. SCH 23390, a halobenzazepine, is a selective antagonist ...

CAS 7416-34-4 Molindone

Molindone
(CAS: 7416-34-4)

Molindone is dopamine D2 receptor antagonist which can be used in the treatment of schizophrenia. Molindone can block the effects of dopamine in the brain, lead...

CAS 99755-59-6 Rotigotine

Rotigotine
(CAS: 99755-59-6)

Rotigotine is a dopamine agonist of the non-ergoline class of medications indicated for the treatment of Parkinson's disease (PD) and Willis-Ekbom Disease.

CAS 1227675-51-5 SCH 39166 hydrobromide

SCH 39166 hydrobromide
(CAS: 1227675-51-5)

SCH 39166 hydrobromide is a high affinity dopamine D1/D5 receptor antagonist (Ki = 1.2, 2, 980, 5520, 80 and 731 nM for binding to D1, D5, D2, D4, 5-HT and α2a ...

CAS 146-54-3 Triflupromazine

Triflupromazine
(CAS: 146-54-3)

Triflupromazine, a phenothiazin derivative, has been found to be a D2 dopamine receptor antagonist that could probably used as a tranquilizer and antipsychotic ...

CAS 85798-08-9 (-)-Quinpirole hydrochloride

(-)-Quinpirole hydrochloride
(CAS: 85798-08-9)

(-)-Quinpirole hydrochloride is a selective dopamine D2 receptor agonist, with high affinity for the D2 and D3 dopamine receptor subtypes (Ki values are 4.8, ~2...

CAS 81226-60-0 L-741,626

L-741,626
(CAS: 81226-60-0)

L-741,626 is a selective and potent D2 dopamine receptor antagonist. It is centrally active following systemic administration in vivo. It inhibits quinpirole-st...

Chemical Structure

CAS 97612-24-3 Eticlopride hydrochloride

Quick Inquiry

Verification code

Featured Items